CHEK2 and cancer: Of 65 individuals with CHEK2, there were 50% with a family history of breast cancer, 34% with a family history of breast cancer at a young age at <age 50, 14.3% with a family history of ovarian cancer, and 21% with other HBOC‐related cancers in their families.